Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities (Details)

v3.20.4
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accrued Expenses and Other Current Liabilities    
Compensation and benefits $ 2,919 $ 1,786
Commercial expenses 605  
Legal expenses 784 86
Pharmaceutical development expenses 413 445
Accrued interest   18
Other accrued expenses and other current liabilities 447 68
Total accrued expenses and other current liabilities $ 5,168 $ 2,403